Tara M. Harris

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

A process evaluation of Ontario, Canada's 2023-24 older-adult RSV vaccination program.

A process evaluation of Ontario, Canada's 2023-24 older-adult RSV vaccination program.

Journal: Human vaccines & immunotherapeutics
Published: August 25, 2025

Invasive Pneumococcal Disease Epidemiology and Serotype Replacement After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Ontario, Canada, 2007-2022.

Invasive Pneumococcal Disease Epidemiology and Serotype Replacement After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Ontario, Canada, 2007-2022.

Journal: Open forum infectious diseases
Published: January 31, 2024

Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada.

Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada.

Journal: JAMA pediatrics
Published: February 27, 2023

Methodological changes implemented over time to support accurate and timely COVID-19 vaccine coverage estimates: Ontario, Canada.

Methodological changes implemented over time to support accurate and timely COVID-19 vaccine coverage estimates: Ontario, Canada.

Journal: Vaccine
Published: November 15, 2022

Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.

Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.

Journal: JAMA network open
Published: June 24, 2022

The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017.

The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017.

Journal: PloS one
Published: July 18, 2019

Assessing safety of Ontario's publicly funded MMR and MMRV immunization programs, 2012 to 2016.

Assessing safety of Ontario's publicly funded MMR and MMRV immunization programs, 2012 to 2016.

Journal: Paediatrics & child health
Published: November 27, 2018

Demonstration of background rates of three conditions of interest for vaccine safety surveillance.

Demonstration of background rates of three conditions of interest for vaccine safety surveillance.

Journal: PloS one
Published: September 14, 2018

Equity and impact: Ontario's infant rotavirus immunization program five years following implementation. A population-based cohort study.

Equity and impact: Ontario's infant rotavirus immunization program five years following implementation. A population-based cohort study.

Journal: Vaccine
Published: September 11, 2018

Assessment of sex-specific differences in adverse events following immunization reporting in Ontario, 2012-15.

Assessment of sex-specific differences in adverse events following immunization reporting in Ontario, 2012-15.

Journal: Vaccine
Published: February 01, 2017

Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.

Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.

Journal: Vaccine
Published: March 09, 2016

Population-Level Impact of Ontario's Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects.

Population-Level Impact of Ontario's Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects.

Journal: PloS one
Published: January 08, 2016
Showing 1-12 of 16

Last Updated: 09/26/2026